Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
Clinical trial NCT02518529 · COMPLETED
Trial details
- NCT number
- NCT02518529
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2002-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.